-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US75886FAF45-
Regeneron Pharmaceuticals Inc.Börse NasdaqISIN US75886F1075 WKN: 881535Symbol REGN
-
Regeneron PharmaceuticalsBörse Xetra FrankfurtISIN US75886FAE79EURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse FrankfurtEURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse BerlinEURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse StuttgartEURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse MünchenEURSymbol RGO
-
REGENERON PHARMACEUTICALSBörse Quotrix System der Börse DüsseldorfEURSymbol RGO
-
REGENERON PHARMACEUTICALSBörse Börse DüsseldorfEURSymbol RGO
-
REGENERON PHARMACEUTICALSBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol RGO
-
REGENERON PHARMACEUTICALSBörse Gettex System der Börse MünchenEURSymbol RGO
-
Regeneron PharmaceuticalsBörse Börse Stuttgart
-
Regeneron PharmaceuticalsBörse NasdaqISIN US75886F1075 WKN: 881535USDSymbol REGN
-
Regeneron PharmaceuticalsBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US75886FAF45
-
Regeneron Pharmaceuticals, Inc.Börse London Stock Exchange
-
Regeneron Pharmaceuticals, Inc.Börse BVMF
-
Regeneron Pharmaceuticals, Inc.Börse Bolsa Mexicana de Valore Mexiko-Stadt
-
ISIN US75886FAF45
Firmenname
Regeneron Pharmaceuticals, Inc
Marktkapitalisierung
54.389.120.217 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
54.622.801.920 oder 57.888.000.000 oder 50.656.558.731
Mitarbeiter
10.207 (+- 19%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
8.314 oder 12.099 Mitarbeiter
Anzahl Aktien
104.857.294
KGV
19.08 (+- 2%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
18.76 oder 19.4
EBITDA 3.348.999.936
PEGRatio 0.9353
Buchwert 96.011
Regeneron Pharmaceuticals underperformed den DAX um -36 % vom 08.01.2016 bis 02.07.2021
Aktionärsstruktur der Regeneron Pharmaceuticals, Inc
Portrait der Regeneron Pharmaceuticals Aktie
Das Unternehmen Regeneron Pharmaceuticals, Inc aus USA beschäftigt 10.207 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.
Die Regeneron Pharmaceuticals Aktie konnte seit dem 08.01.2016 eine Rendite von 23% erwirtschaften.
Das Unternehmen Regeneron Pharmaceuticals, Inc ist in mehr als 79 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet Regeneron Pharmaceuticals mit 5,83% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Regeneron Pharmaceuticals Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Regeneron Pharmaceuticals, Inc am höchsten gewichtet ist Insgesamt in 79 ETFs enthalten
Dir gefallen die Informationen zu Regeneron Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Regeneron Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Regeneron Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Regeneron Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
184 News & Informationen zur Regeneron Pharmaceuticals Aktie
Meyer Handelman Co Buys Travel+Leisure Co, TJX Inc, Salesforce.com Inc, Sells Travel+Leisure Co, Viatris Inc,
GuruFocus Article or News written by insider and the topic is about:
VC Health Pulse : General Catalyst, HCA Healthcare Team Up on Digital Innovation; Illumina Completes Deal for Life-Sciences Firm Grail
Good day. Venture capitalists are betting on a variety of startups seeking to cure autoimmune diseases.
Autoimmune diseases, in which the immune system attacks the body's own tissue,… | August 19, 2021
Cathie Wood’s ARK Invest Sells Over 40,000 Shares of Baidu – 24
One of Cathie Wood's Ark Invest funds sold over 40,000 shares of Baidu on August 18.
Why Regeneron Pharmaceuticals (REGN) Isn't Done Growing Earnings Yet
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Regeneron Pharmaceuticals (REGN).
Premier Asset Management Llc Buys Coupa Software Inc, Hess Corp, Baker Hughes Co, Sells General Electric Co, Fiserv Inc, Qualcomm Inc
GuruFocus Article or News written by insider and the topic is about:
A.R.T. Advisors, LLC Buys Pfizer Inc, ASML Holding NV, Regeneron Pharmaceuticals Inc, Sells Amazon.com Inc, Booking Holdings Inc, Morgan Stanley
GuruFocus Article or News written by insider and the topic is about:
Florida and Texas are turning to antibody treatments as COVID-19 cases surge
Doctors are increasingly turning to antibody drugs in a bid to keep hospitals from being overwhelmed by a surge of Covid-19 cases, a turnabout after months…
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.
Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market …
JD.com And Tesla Lead The Nasdaq Lower Tuesday
U.S. indices were trading lower Tuesday amid macro uncertainty due to COVID-19 concerns. Investors also weighed today's Home Depot (NYSE: HD) …
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs.
Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market …
Point72 Asset Management Buys Salesforce.com Inc, Amazon.com Inc, Analog Devices Inc, Sells Applied Materials Inc, DXC Technology Co, Baidu Inc
GuruFocus Article or News written by insider and the topic is about:
Karani Asset Management LLC Buys Tesla Inc, Trupanion Inc, Shake Shack Inc, Sells Texas Pacific Land Corp, Alnylam Pharmaceuticals Inc, Guidewire Software Inc
GuruFocus Article or News written by insider and the topic is about:
Kiniksa Announces Launch Of ARCALYST Named Patient Program
– Named Patient Program supports patient access to ARCALYST ® (rilonacept) in countries where ARCALYST is not currently commercially available –
HAMILTON,
AtonRa Partners Buys Marvell Technology Inc, SolarEdge Technologies Inc, Veeva Systems Inc, Sells Guardant Health Inc, Vertex Pharmaceuticals Inc, Illumina Inc
GuruFocus Article or News written by insider and the topic is about:
Y-Intercept (Hong Kong) Ltd Buys KLA Corp, Archer-Daniels Midland Co, Regeneron Pharmaceuticals Inc, Sells Apple Inc, Baidu Inc, Baxter International Inc
GuruFocus Article or News written by insider and the topic is about:
eBay And AMD Lead The QQQ Friday
U.S. indices traded flat for much of Friday’s session as concerns over the COVID-19 Delta variant continues to cause market uncertainty. The …
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.04% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.04%
US stocks eke out gains, leaving S&P 500 higher for the week
Stocks managed to eke out tiny gains after another day of wobbly trading, leaving the S&P 500 higher for the second week in a row. The benchmark index added 0.2% Friday, its fourth straight gain. The Dow Jones Industrial Average and the Nasdaq edged up less than 0.1%. Small-company stocks fell, and Treasury yields dropped. There was little for investors to like in an economic report showing a big drop in consumer confidence last month as the delta variant of COVID-19 spread. The yield on the 10-year Treasury note fell to 1.29%.
US stock indexes edge mostly lower; S&P 500 eyes weekly gain
Stock indexes inched mostly lower Friday afternoon as gains in technology and health care companies were checked by weakness in banks and other sectors.
5 Top Rated Stocks That Crushed Earnings Estimates This Quarter By StockNews
5 Top Rated Stocks That Crushed Earnings Estimates This Quarter
FDA expected to authorize an extra COVID-19 dose for people with weak immune systems in the first regulatory OK for a booster shot in the U.S.
The U.S. is expected to soon authorize two COVID-19 booster shots for people with compromised immune systems in a move that underscores the risk that the…
Is Regeneron Pharmaceuticals (REGN) Stock Outpacing Its Medical Peers This Year?
Is (REGN) Outperforming Other Medical Stocks This Year?
Cathie Wood’s ARK Invest Sells Over 280,000 Shares of Twitter – 24
One of Cathie Wood's ARK Invest funds sold over 280,000 shares of Twitter on August 11.
Cathie Wood’s ARK Invest Dumps Nearly $39 Million Worth of Netflix Stock – 24
One of Cathie Wood's ARK Invest funds sold over 75,000 shares of Netflix on August 10.
Cathie Wood’s ARK Invest Sells for 8
Here's a look at the ARK Invest sells for August 10, 2021.
Tom Gayner's Top 5 2nd-Quarter Trades
GuruFocus Article or News written by Graham Griffin and the topic is about: Guru charges up technology exposure
Were Hedge Funds Right About Piling Into Aon plc (AON)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors…
Markel Gayner Asset Management Corp Buys Regeneron Pharmaceuticals Inc, Texas Pacific Land Corp, Marvell Technology Inc, Sells Electronic Arts Inc
GuruFocus Article or News written by insider and the topic is about:
ROUNDUP/Aktien New York Schluss: Starkes Finale – S&P 500 fast auf Rekordhoch
ROUNDUP/Aktien New York Schluss: Starkes Finale – S&P 500 fast auf Rekordhoch | Nachricht | finanzen.net
Regeneron Pharmaceuticals Inc (REGN) Q2 2021 Earnings Call Transcript
REGN earnings call for the period ending June 30, 2021.
Regeneron Pharmaceuticals Inc. (REGN) CEO Leonard Schleifer on Q2 2021 Results – Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) Q2 2021 Earnings Conference Call August 05, 2021 08:30 AM ET Company Participants Justin Holko – VP of IR Leonard Schleifer – Founder, President…
Regeneron Pharmaceuticals Inc (REGN) EVP Commercial Marion Mccourt Sold $577,120 of Shares
GuruFocus Article or News written by insider and the topic is about:
Regeneron Pharmaceuticals, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:REGN)
The following slide deck was published by Regeneron Pharmaceuticals, Inc.
Regeneron sees uptick in COVID-19 therapy use as cases rise By Reuters
Regeneron sees uptick in COVID-19 therapy use as cases rise
10 Best Biotech Stocks to Buy According to Alan Frazier’s Frazier Healthcare Partners
In this article, we discuss the 10 best biotech stocks to buy according to Alan Frazier.
Regeneron sees uptick in COVID-19 therapy use as cases rise
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
Cathie Wood’s ARK Invest Sells Over 60,000 Shares of Square – 24
One of Cathie Wood's Ark Invest exchange-traded funds sold over 60,000 shares of Square on August 4.
Regeneron/Sanofi's Libtayo Combined With Chemo Reduced Death By 29% In Non-small Cell Lung Cancer
Regeneron Pharmaceuticals Inc. (REGN) and Sanofi's (SNY) phase III trial of Libtayo combined with chemotherapy has been stopped early due to significant improvement in overall survival in patients with first-line advanced non-small cell lung cancer.
Intellia Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Recent Company Progress
Established proof of concept for the Company’s modular in vivo delivery platform with first-ever clinical data from systemically administered CRISPR genome…
Regeneron shares jump 3.3% premarket after earnings blow past estimates; COVID antibody sales total $2.59 billion
Regeneron Pharmaceuticals Inc. shares undefined jumped 3.3% in premarket trade Thursday, after . Tarrytown, New York-based Regeneron posted net income of…